Search for: "In re: Abbott Laboratories"
Results 81 - 100
of 236
Sort by Relevance
|
Sort by Date
18 Jun 2014, 1:00 pm
One of the more well-known products is AndroGel, from AbbVie, a subsidiary of Abbott Laboratories. [read post]
29 May 2014, 5:00 am
Wyeth-Ayerst Laboratories, 1994 WL 532091, at *1 (E.D. [read post]
22 Apr 2014, 7:41 am
Procedural HistoryThe New Drug Application (NDA) for the Tarka® product was approved by the Food and Drug Administration in 1996 and acquired by Abbott Laboratories in 2001. [read post]
21 Feb 2014, 8:53 am
” In re Fosamax Products Liability Litigation, 2013 WL 174416, at *1 (S.D.N.Y. [read post]
7 Jan 2014, 5:26 pm
Abbott Laboratories spent $80 million advertising AndroGel last year. [read post]
30 Dec 2013, 5:25 am
In re Fosamax Products Liability Litigation, ___ F. [read post]
14 Dec 2013, 1:37 pm
Abbott Laboratories spent $80 million advertising AndroGel last year. [read post]
17 Oct 2013, 5:00 am
The learned intermediary rule could be Bob Dylan (I know, we’re showing our age, here). [read post]
6 Aug 2013, 12:18 pm
So how does In re Darvocet differ from In re Abbott Laboratories? [read post]
25 Jun 2013, 1:27 pm
Abbott Laboratories, 201 F.3d 883 (7th Cir. 2000), didn’t apply because the survey wasn’t being used to define the meaning of that phrase. [read post]
25 Apr 2013, 5:00 am
We’re bloggers. [read post]
16 Apr 2013, 6:51 am
Wyeth-Ayerst Laboratories, 385 F.3d 961 (6th Cir. 2004)), and the plaintiffs played the same non-severability card. [read post]
5 Apr 2013, 1:01 pm
Abbott Laboratories, C.A. [read post]
6 Mar 2013, 4:30 am
Abbott Laboratories, 2013 U.S. [read post]
11 Jan 2013, 11:12 am
Abbott Laboratories, 2012 WL 6681704 (S.D.N.Y. [read post]
7 Jan 2013, 3:30 am
They’re lucky to find one. [read post]
4 Jan 2013, 4:15 am
Abbott Laboratories paid $1.4 billion. [read post]
28 Dec 2012, 1:57 pm
In re Schering Plough Corp. [read post]
21 Dec 2012, 11:41 am
So we’re hopeful that the worst decision of 2012 might produce the best of 2013. [read post]
23 Oct 2012, 4:01 am
See In re Abbott Laboratories Inc., No. 12-8020 (7th Cir. 10/16/12). [read post]
